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Tetrandrine, a bisbenylisoquionoline alkaloid, is an active component present in 
Stephania Tetrandra. It is widely used in Chinese medicine as a diuretic, an 
expectorant and a cathartic. Stephania Tetrandra which is known to have 
pharmaceutical properties is used for treating inflammation, fever and arthritis. 
However, the detail mechanism of its activity has not yet been known. 
To study the mechanism of its pharmacological actions, mainly on its anti-cancer 
effect, two hepatocarcinoma cell lines, HuH-7 and JHH-4, and normal liver cell line 
WRL68 were used as control. MTT assays were carried out to study the concentration 
and the incubation effects on the viabilities of different hepatocarcinoma cell lines in 
vitro. The IC50 of 24 and 48 hours for HuH-7 cells were found to be 20.8 uM and 8.0 
uM, respectively. The IC50 for 24, 48 and 72 hours of incubation for JHH-4 cells were 
found to be 40.0 uM, 28.5 uM and 12.3 uM, respectively. After HuH-7 was treated 
with Tetrandrine for 24 hours, DNA laddering was observed using DNA 
fragmentation assay. Flow cytometry was used to study the effects of Tetrandrine on 
cell cycle distribution ofHuH-7. Gi phase cell cycle arrest was observed in 
dose-dependent manner. The expression levels of genes associated with apoptosis 
were investigated using RT-PCR. The gene expression levels of box and p21 were 
found to be elevated in dose-dependent manner after Tetrandrine treatment in both the 
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hepatocarcinoma cell lines. In addition, dose-dependent suppression ofbcl-2 and 
survivin gene expression levels were observed after treatment. Western blot analysis 
of protein expression levels in the cancer cells showed that p21, Bax, cleaved PARP 
and cleaved caspase 9 levels increased with Tetrandrine concentrations while that of 
PCNA, Bcl-2, full length PARP, pro-caspase 3 and pro-caspase 9 decreased. The 
overall results demonstrated that Tetrandrine can significantly inhibit the growth of 
the two hepatocarcinoma cell lines through the induction of apoptosis. It suggests that 






本實驗利用HUH - 7和JHH - 4這兩種不同的體外人肝癌细胞和正常肝細胞 
WRL68作模型，來硏究粉防己鹼抗腫瘤的藥理作用機制。透過細胞存活檢測來 
硏究粉防己鹼的濃度與培養時間對不同體外人肝癌细胞存活率的影響�HuH-7 
细胞在廿四及四十八小時的IC50値分別爲20.8 u M及8 . 0 uM ° JHH-4细胞在廿 






cleaved PARP 及 cleaved caspase 9 蛋白分量上升；同時 P C N A � B c l - 2 � f u l l length 
PARP�pro-caspase 3 及 pro-caspase 9 蛋白分量貝Ij減少 ° 
總括而言，粉防己鹼可以透過细胞凋亡作用來有效抑制兩種體外人肝癌细胞的 
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Chapter 1 Introduction 
1.1 Cancer 
Cancer, the malignant neoplasm, is a group of diseases that display uncontrolled 
growth, dedifferentiation, loss of its function, invasiveness and spread of abnormal 
cells. Cancer can be caused by both the external and internal factors. External factors 
include tobacco, chemicals, radiations and infectious organisms. Internal factors 
include hormones, inherited mutations and the immune conditions. There are many 
causes of cancers including certain pathogen infections (e.g. HPV and cervical cancer, 
H. pylori with stomach cancer), physical carcinogens (e.g. UV radiation) and " 
chemical carcinogens (e.g. aflatoxin, components in tobacco smoke). 
Cancer is the leading cause of human death worldwide. It accounts for about 13% of 
all death in 2004 which is believed to be higher around these years. Among the 
cancers, liver cancer is the fifth most common cancer around the world (WHO, 2009). 
Liver cancer is highly metastatic. Once it reaches the more advanced stages, cancer 
has most probably spread to other locations. There is no current cure for the terminal 
cancer. So patients with liver cancer have high lethal rate. 
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1.2 Hepatocellular carcinoma (HCC) 
Liver is an important organ inside the body which has many functions such as 
detoxification and metabolism. It composes of different cell types. So liver cancer 
refers to various kinds of hepatic neoplasm originating from the cells within the liver. 
It includes cholangiocarcinomas, hepatoblastoma, angiosarcoma, hemangiosarcomas 
and hepatocellular carcinoma. Among these carcinomas, hepatocellular carcinoma is 
the most prevalent type as the hepatocyte makes up over 80% of the liver. 
Hepatocellular carcinoma (HCC) is also called as malignant hepatoma. It is a primary 
malignancy of the hepatocyte. Among all the cases of HCC, most of them are 
secondary including those due to the viral infections such as hepatitis B and hepatitis 
C, and cirrhosis. For those countries where hepatitis is not an endemic, most of the 
HCC is due to metastasis of other cancers within the body. HCC accounts for 80-90% 
of the liver cancer which is one of the most frequent types of cancer throughout the 
world. The prevalence of HCC in the developing countries is higher than that in the 
developed countries 
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1.2.1 Risk factors causing HCC 
I. Infection by hepatitis viruses 
The most common risk factor for the hepatocellular carcinoma is the hepatitis B viral 
(HBV) or hepatitis C viral (HCV) infection. About one fourth of the carrier population 
will develop liver cirrhosis and may lead to liver cancer. Hepatitis B is endemic in 
China and other parts of the Asia. HBV is transmitted through people by the contact 
of blood or body fluids. The prevalence of HCV infection in some countries in Africa, 
the Eastern Mediterranean, South-East Asia and the Western Pacific is high. HCV is 
transmitted mainly through the direct contact of human blood. 
Both the HBV and HCV can induce carcinogenesis of the liver. However, the , 
molecular mechanisms for the two infections are different. 
HBV is a DNA virus. It targets the human liver cells and integrates its HBV genome 
into the host DNA. Integration of the HBV genome is found to be always 
accompanied by rearrangement of DNA where it flanks (Feitelson, 1999). This may 
cause microdeletion, chromosomal inversion or translocation in the host DNA leading 
to chromosome instability (Tamori et al., 2003). When these arrangements occur in 
genes that are related to cancers such as tumor suppressor genes, this may lead to 
carcinogenesis. 
Besides this mechanism, HBxAg is believed to be associated with 
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hepatocarcinogenicity. HBxAg is a protein encoded by the HBV viral genome. 
Studies showed that HBxAg may alter the expression patterns of the genes. This may 
be due to its binding to several transcription factors in the host nucleus. It may also 
alter the activity of several signal transduction pathways in the cytoplasm (Feitelson, 
1999). Transgenic mice studies have also shown that HBxAg stimulates the 
production of transforming growth factor beta 1 in the mice and developed HCC 
(Feitelson, 1999). 
HCV is a RNA virus and is unable to conjugate its genome into the host genome. 
Hence the HCV-associated HCC is not due to the genome integration. It is believed 
that the viral gene products interfere with the major cellular transduction pathways 
such that the proliferation rate of the hepatocyte increases leading to HCC 
(Stankovic-Djordjevic et al., 2007). 
11. Alcoholism 
Chronic alcohol consumption, only severe but not moderate, is another important risk 
factor for HCC development. It is well-known that alcoholism can cause various 
kinds of liver diseases such as cirrhosis, hepatitis and may finally lead to HCC. 
Among those, liver cirrhosis appreciably increases the risk of having HCC. DNA 
damages are induced during carcinogenesis. There are several ways that alcohol can 
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lead to HCC. 
Firstly, several carcinogenic substances such as polycyclic hydrocarbons and 
nitrosamines are found in alcoholic beverages. Liver is the first site of detoxification 
so that it is the first organ subjected to the attack of such carcinogens. Secondly, 
chronic alcohol consumption not only increases the activities of certain microsomal 
drug-detoxifying enzymes but also the enzymes converting exogenous compounds to 
toxic compounds. With the increased ability to metabolize substances, there is an 
increased rate of converting those substances into carcinogens after metabolism. One 
of the examples is dimethylnitrosamine (DMN). Activation of this compound to a 
DNA-methylating agent requires N-demethylation. Alcohol consumption can increase 
the activities of enzymes responsible for its activation and causing (DNA methylation) 
DNA damage. Normal cells are able to repair the damaged DNA. If the DNA is not 
repaired, apoptosis will be switched on. However, alcohol can inhibit the 
DNA-repairing enzymes in the liver leaving the damaged DNA unrepaired (Lieber et 
al., 1986). Thirdly, alcoholism can lead to liver cirrhosis. This decreases the ability for 
the liver cell to detoxify carcinogens leading to the increase in carcinogens 
concentrations. As liver is the organ for metabolism, liver cells is the most probable 
target of the carcinogens which finally leads to HCC. 
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III. Anatoxins 
Aflatoxins are toxins produced by many types of fungi. They are both teratogenic and 
carcinogenic. There are many types of aflatoxins: Bi, B2, Gi, G2 and Mi. Aflatoxin-Bi 
is known to be a very potent carcinogen for humans and animals. Consumption of 
food contaminated with the toxins can lead to carcinogenesis. Corn and com products, 
peanuts and tree nuts are the most prone to contamination. 
The carcinogenic property of aflatoxin-Bi is thought to be related to the metabolism 
by the liver. Metabolism of aflatoxin-Bi produces hydroxylated species aflatoxin-Mi 
and finally forms DNA and protein adducts (Groopman et al” 1985). The formation of 
DNA adducts is thought to be selective towards p53 gene, the tumor suppressor gene. 
A G to T transversion at the third position of codon 249 of the p53 gene resulting in 
the change of arginine to serine is common for those patients exposed to dietary 
aflatoxin. This may contribute to its carcinogenicity. In the examination of aflatoxin 
exposure, aflatoxin-DNA adduct is used as marker. It is also found that the higher the 
exposure level to aflatoxin, the earlier the onset of the HCC (Chen et al.,1997). 
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1.2.2 Molecular mechanisms of HCC 
I. The p53 pathway 
The wildtype p53 gene acts as tumor suppressor as it controls the cell cycle 
progression and cell division by regulating the transcriptional activation of some 
important grow regulatory genes (Katiyar et al.，2000). In normal cells, the p53 
protein expression level is low. Once the cell is under stress, the p53 protein 
expression will be up-regulated and this may lead to cell cycle arrest or apoptosis. The 
tumor suppressor p53 gene is inactivated causing half of the all human tumors by a 
single point mutation. Other cases are due to the defect of p53 signaling pathway such 
that cell cycle arrest and the apoptotic process are defective though the p53 protein is 
expressed at a normal level (Aravalli et al., 2008). Aflatoxin-Bi causes the point 
mutation of the codon 249 in the p53 tumor suppressor gene which is suspected to be 
one of the risk factors of HCC. 
For those areas with high incidence ofHBV infection, p53 plays another role in the 
development of HCC. HCC development in this case is not fully due to the mutation 
of p53 gene. Viral product ofHBV, the viral transcriptional transactivating protein 
HBX, can bind to p53 protein and inhibits the sequence-specific DNA binding and the 
p53-mediated transcriptional activation activities (Katiyar et al., 2000). 
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II. Genetic instability 
With the HBV-associated HCC, viral genome integration to the host chromosomal 
DNA which is highly random always causes extensive rearrangement of the integrated 
viral DNA and the flanked DNA sequences (Feitelson，1999). The DNA sequence 
often results in inverted duplication, translocations, deletions and probably 
recombination (Staib et al.，2003). The cirrhotic parenchyma cells are reported with 
allelic loss and microsatellite instability adjacent to the HCC. These chromosome 
alterations will lead to the loss of some genes, more importantly the tumor 
suppressive genes. The loss of control to cell cycle, differentiation and apoptosis 
causes cancers. 
1.2.3. Treatment 
For the early stage of HCC, cancer patients have higher survival rate with proper 
treatments. Radiation therapy, chemotherapy, liver transplantation, surgical resection, 
radiofrequency treatment and ethanol injection are common treatments for early stage 
of HCC. However, the efficiencies of these treatments become much lower for the 
advanced stages as HCC is a highly chemoresistant tumor. The cancer cells will 
develop multi-drug resistance during chemotherapy and the response rate is less than 
8 
10-20% (Luk et al., 1997). The doses of the drugs used have to be increased in order 
to achieve cancer-killing effect. This strengthens the side effects of chemotherapy. 
Though surgical resection is the most efficient way for curing HCC, it may not be 
applicable for those patients with large tumor as the removal of such a large section of 
liver tissue will lead to severe loss of liver functions. Having excellent liver function 
is one of the important criteria for surgical resection. Besides, the frequency of the 
tumor recurrence for HCC is high. And also, HCC is usually metastatic. Removal of 
tumor in liver by surgical resection is no longer useful (Yoo et al., 2002). 
Radiofrequency treatment and ethanol injection are also due to the same reasons. 
There is no effective treatment for the advanced stage of HCC. Though chemotherapy 
shows some effectiveness, the result of the treatment is poor. Among anticancer 
agents used to treat HCC, 5-flurouracil (5-FU), cisplatin and a-interferon have shown 
some effectiveness. No single anti-cancer drug is effective in treating HCC. A 
combination of different anti-cancer agents is used (Tanikawa, 2001). Arterial 
infusion of multiple drugs with systemic fluorouracil, Velban or methotraxate is 
common treatment (Lee, 1983). However, even using multiple agents, the 5-year 
survival rate of HCC patients is still very low as HCC can easily develop multi-drug 
resistance. Due to such a low 5-year survival rate, new treatment has to be developed. 
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1.3 Tetrandrine (Tet) - A naturally occurring compound from Traditional 
Chinese Medicine (TCM) 
1.3.1 Tradition Chinese Medicine (TCM) 
Herbal medicines have been used in China for several decades to treat various kinds 
of diseases. TCM represents a holistic approach that treats the entire human body. In 
TCM treatment, the herbalists emphasize the "harmony", which is holding a balance 
between Yin (陰）and Yang (陽).The main purpose of holding this balance is to 
maintain the health of the patient and to treat the disease rather than killing the 
pathogens. This is different from the Western science and medicine which focus on 
mechanism. The cellular, molecular and pharmacological level of the disease 
analyzed are concerned rather than the analysis of the whole human body. Hence, 
using TCM is a good method to treat certain kinds of diseases such as endocrine 
disorder, chronic inflammation and even, cancers. 
Some of the natural compounds such as vinca alkaloids and taxanes are used in 
chemotherapy to treat different kinds of cancers. Vinca alkaloids can inhibit the 
assembly of tubulin so that mitotic spindles cannot be formed to suppress the 
proliferation of cancer cells. Taxol can inhibit cell proliferation by stabilizing the 
mitotic spindles such that they are unable to disintegrate during anaphase. The sister 
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chromatids are unable to separate. These natural products shows significant cancer 
killing effect suggesting that there are many potential anti-cancer agents within our 
natural environment. As TCM uses herbs as medicines to treat various kinds of 
diseases, scanning the herbal medicines for anti-cancer agents would be a good start. 
For the past decade, TCM shows promising result in killing different kinds of cancers. 
There are extensive studies on TCM as it is a good source of anti-cancer agents. It is 
hoped that new drugs can be developed and can be used to treat cancers of advanced 
stages. It may also be used as a complement with the current Western medicin6 in 
chemotherapy. 
TCM is different from Western medicine that it is used in formulation in which a 
mixture of different herbal medicine is put together. The use of Chinese medicine is 
usually for a complex remedy. Use of an individual herb is rare. It is difficult to 
identify the active components that can give anti-cancer effects. So identification of 
the active components is important for the purification of the anti-cancer compounds 
from specific kinds of herbs such that a suitable amount of the active components can 
be prescribed to patients to achieve their pharmacological effects. Determination of 
the structure of the active components is also important in the development of new 
drugs. The active components may be used as lead compounds to synthesize more 
potent anti-cancer agents with fewer side effects. 
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1.3.2 Tetrandrine 
Tetrandrine (TET, C38H42N2O6) having molar mass of 622.74988 g/mol is a 
bisbenzylisoquinoline alkaloid, a naturally occurring compound isolated from the root 
of Stephania tetrandra S. Moore. This herb is known as Hang Fang Chi (�漢防己）in 
Chinese. 
Fig. 1.3-1: Structure of Tetradrine 
I •“ j 1:1: ^ . 
‘ V ; r T , 
[Adapted from: 
http://www.sigmaaldrichxom/catalog/ProductDetail.do?N4=T2695|FLUKA&N5=SE 
ARCH CONCAT PNO|BRAND KEY&F=SPEC 20/10/2010] 
The plant has been used in traditional Chinese medicine as an anti-inflammatory, 
anti-rheumatic and anti-hypertensive agent (Ng, 2006). TET has a broad spectrum of 
pharmacological actions. It is well-known that it possesses immunosuppressive, 
^ I 
non-selective Ca channel blocking, anti-proliferative, and free radical scavenging 
effects. It was reported that apoptosis was induced in human leukemic U937 cells 
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(Jang et al., 2004). It can also inhibit the proliferation ofHeLa cells and HepG2 cells 
in vitro and to suppress ascites tumors in mice (Yoo et al., 2002). 
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1.4 Molecular mechanisms of apoptosis 
1.4.1 Overview of apoptosis 
Apoptosis, also called the programmed cell death, is an important process occurring 
within multicellular organisms. In this process, the cells are actively participating in 
their own death. Apoptosis is also referred to cell suicide. It is an essential component 
for normal development and health of the multicellular organism (apoptosis). The 
cells will die in a controlled, regulated manner in response to different stimuli such as 
cell stress, DNA damage or virus infection. As this type of cell death is 
well-controlled, it can be easily distinguished from the other type of cell death, 
necrosis, which is an uncontrolled one. 
Apoptosis occurs during the normal development of a multicellular organism. The 
combination of apoptosis and cell proliferation can achieve the shaping effect of 
tissues such as the apoptosis occurs between the toes and the fingers in order to allow 
them for separation and form the digit. The degeneration of the tail of tadpole when it 
is growing into a frog also involves apoptosis. Apoptosis is also important in the 
regulation of the immune system. Ineffective or self-reactive T-cells are removed 
before they are released into the blood stream. Problems associated with the 
regulation of apoptosis would develop a number of diseases. Cancers are diseases due 
to too little apoptosis leading to the uncontrolled increase in cell number. Those 
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cancers that normally undergo mutations could ignore the cellular signals that regulate 
their growth, escape from the apoptotic process and self-proliferate. 
Cells undergoing apoptosis show characteristic morphological changes. There will be 
cell shrinkage, chromosome condensation, nuclear fragmentation (also called 
pyknosis), membrane blebbing and the formation of apoptotic bodies. The mechanism 
of apoptosis is complex. It can be initiated through two pathways, the extrinsic and 
the intrinsic pathways. These two pathways involve different mechanisms in initiating 
the apoptosis in cells. In general, the two pathways will finally converge and trigger 
the caspase cascade. Bcl-2 protein family is a large group of proteins playing an 
important role in this process. -
1.4.2 Caspase cascade 
Caspase, the cysteine-aspartate protease, belongs to the group of cystein protease. 
Caspases are the major executors of the apoptotic process. They exist in pro-forms or 
zymogens within the cells. The zymogens are organized into three structural regions 
which are the N-terminal prodomain, the large and the small subunits. Activation of 
zymogens to the active form of caspases requires the cleavage of the polypeptide 
chain at the aspartate residue. Usually the activation of the zymogens to the active 
form of caspases requires the cleavage of the zymogens at two distinct sites: one of 
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which is located between the N-terminal prodomain and the large subunit while the 
other site is located between the large and the small subunits. The N-terminal 
prodomain will be lost and two of the large subunits and two of the small subunits 
will combine to form a heterotetrameric structure. That is the active forn} of the 
caspase. 
The caspases are divided into three groups: the initiator caspases, the effector caspases 
and the "cytokine processing" caspases. Only the initiator and the effector caspases 
are involved in apoptosis. The third group does not involve in apoptosis but in the 
inflammatory response. 
The initiator caspases (e.g. caspase 2，8，9 and 10) can be distinguished from the 
effector caspases as they have larger prodomains. Their activation is based on the 
binding to the adaptor molecules. They are important in the initiation of the caspase 
cascade. The effector caspases (e.g. caspase 3 and 6) are generally having shorter 
prodomain. They are activated by other caspases and they are the executors of the 
apoptosis. They carry out apoptosis by cleaving the key structural and functional 
proteins such as the cytoskeletal proteins (Pinton et al., 2001). 
The caspase cascade can be activated through two major pathways* - the 
mitochondrial pathway and the extrinsic pathway. Binding of ligands to the death 
receptors recruits adaptor molecules which in turn recruits initiator caspases (e.g. 
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binding of the Fas ligand to the Fas receptor will recruit Fas-associated death domain, 
FADD, which will in turn recruit caspase 8 or 10). These initiator caspases will 
activate the downstream effector caspases, such as caspase 3 and 6. The effector 
caspases bring about cellular changes such that the changes will cause irreversible cell 
death. 
Cellular stresses will induce apoptosis through the intrinsic apoptotic pathway. In this 
pathway, mitochondria also play an important role in the regulation of cell death. The 
release of cytochrome c from the mitochondria due to the formation of permeability 
transition pore, the PT pore, forms a complex with ATP, apoptotic protease activating 
factor-1 (Apaf-1) and procaspase 9. The complex is called apoptosome. The formation 
of apoptosome activates the procaspase 9 into the active caspase 9. The active,caspase 
9 will activate the downstream caspases cascade where pro-caspase 3 is one of its 
target substrate. 
By activating pro-caspase 3 into the active caspase 3, its active form will subsequently 
degrade various intracellular molecules including poly ADP-ribose polymerase 
(PARP) and finally will lead programmed cell death. 
PARP is an enzyme involved in mainly DNA repairing which is one of the main 
cleavage targets of caspase 3. Cleavage of PARP by caspase 3 could lead to cell death 
so that PARP cleavage serves as one of the markers of cells undergoing apoptosis 
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(Fernandes-Alnemri et al., 1994). 
1.4.3 Bcl-2 protein family 
Bcl-2 is a large family of proteins which are involved in the response to apoptosis. It 
is named so as it was isolated as a gene involved in B-cell lymphoma - the B-cell 
lymphoma gene-2. The proteins within the family are divided into three groups 
according to their similarities in structures and their functions. 
Group I : Members in group I such as Bcl-2 and BC1-XL are anti-apoptotic. All of the 
members within this group have four short, conserved Bcl-2 homology (BH) domains 
from BHl to BH4. They possess C-terminal hydrophobic tails which allow them to be 
localized mainly on the outer mitochondria membrane. 
Group II: Members in group II (e.g. Bax and Bak) are pro-apoptotic. Their structures 
are overall similar to those in Group I which have multiple BH domains. 
Group in： Members in this group (e.g. Bid) are pro-apoptotic. This group consists of 
large and diverse collection of proteins. About 12-16 amino acid BH3 domain is 
common between the members. They are also called BH-3 only proteins (Chan and 
Yu, 2004). 
The proteins in the Bcl-2 family control the apoptotic process by regulating the 
release of pro-apoptotic factor, especially the cytochrome c, from the intermembrane 
18 
space to the cytosol (Hengartner, 2000). The sensitivity of the cells to apoptotic 
stimuli depends on the balance between the pro- and anti-apoptotic bcl-2 proteins. 
When there is an excess of pro-apoptotic proteins, the cells are more sensitive to 
apoptosis. When there is an excess of anti-apoptotic proteins，the cells will tend to be 
more resistant to apoptosis. 
Bax is one of the pro-apoptotic proteins in the Bcl-2 family. It is located in the cytosol. 
These pro-apoptotic proteins relay the pro-death signal aroused by various 
stimulations to the central machinery of apoptosis - the mitochondria. Besides 
interacting with the pore proteins on the mitochondrial membrane, leading to the 
release of cytochrome c due to the increased membrane permeability, it is reported 
that Bax can directly induce the release of cytochrome c from isolated mitochondria 
(Narita et al., 1998 and Jurgensmeier et. al., 1998). Bax is an essential protein to 
induce apoptosis by forming heteromeric protein channel on the outer mitochondria 
membrane and release the pro-apoptotic protein from the matrix of mitochondria 
(Jurgensmeier et. al., 1998，Percht et. al., 2005). 
Bcl-2 is an integral protein which is mainly located on the mitochondrial outer 
membrane. It is reported that Bcl-2 seems to work upstream of caspase 3. It can 
prevent the activation of caspase 3 in response to various stimulus and apoptotic 
agents. Bcl-2 is believed to carry out its anti-apoptotic functions by blocking the 
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mitochondrial release of cytochrome c (Yang et al., 1997). 
1.4.4 The role of mitochondria in apoptosis 
Mitochondria which play a key role to initiate the apoptosis are involved in the 
intrinsic apoptotic pathway. Their involvement is indirect and is related to stress. The 
intrinsic pathway involves the change in mitochondrial membrane permeability and 
pro-apoptotic molecules will be subsequently released from the mitochondria. This 
change is induced by stress such as nutrient deprivation and DNA damage. 
Permeablization of the mitochondrial membrane is the key event to initiate apoptosis 
(Berridge et al., 2009). During the initiation process, the transmembrane potential of 
mitochondria collapses. The disruption of the transmembrane potential will lead to the 
opening of a multiprotein complex - the permeability transition pore (PTP). The 
opening of the PTP causes swelling of the mitochondrial matrix which will 
subsequently rupture the outer mitochondrial membrane. This rupture will release the 
pro-apoptotic agents such as cytochrome c from the intermembrane space of the 
mitochondria (Pinton et al, 2001). 
It is well-known that cytochrome c is located within the electron transport chain 
which is responsible for the energy production in the mitochondria. However, it also 
has another important role in mediating apoptosis. Cytochrome c released from the 
20 
intermembrane space of mitochondria will combine with apoptotic protease activating 
factor-1, Apaf-1, and will recruit pro-caspase 9 and ATP to form a multiprotein 
complex, apoptosome. Formation of apoptosome will activate pro-caspase 9 into the 
active caspase 9. The active caspase 9 will activate other effector caspases to carry out 
the execution. 
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1.5 Anti-cancer agents inducing apoptosis are new targets , 
It is obvious that the formation of cancer is due to the uncontrolled cell proliferation 
which is caused by the defects in apoptotic pathways within the cancer cells. DNA 
mutation followed by the impairment of DNA repair is the major cause of the cancer 
formation. The unrepaired DNA is allowed to pass on to the daughter cells where 
mutation accumulates and finally leads to cancer. 
The current anti-cancer agents used in chemotherapy are mostly cytotoxic drugs, or 
sometimes hormones. Alkylating agents such as cisplatin, plant derivatives such as 
vinca alkaloids are commonly used in chemotherapy. Alkylating agents such as 
cisplatin usually have two functional groups that can covalently bonded to the two 
DNA single strands, acting like a bridge, or intrastrand linking to two adjacent 
guanine nucleotides to prevent the DNA replication. Vinca alkaloids are natural plant 
derivatives. They can affect the microtubule function so that mitotic spindle cannot 
work properly. Methotrexate is another cytotoxic drug that is widely used in cancer 
chemotherapy. It is a folate antagonist which acts as a competitive inhibitor of folates 
for dihydrofolate reductase. Inhibition of dihydrofolate reductase reduces purine 
nucleotides synthesis and hence inhibits the DNA synthesis. 
These cytotoxic drugs are more or less non-selective, targeting the rapidly dividing 
cells which is one of the characteristics of cancer cells. Other normal but rapidly 
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dividing cells including epithelial cells on the gastrointestinal tract, cells in the hair 
follicles and bones are also susceptible for the action of these drugs. Hence these 
normal cells will also be killed leading to GI upset and many other side effects when 
taking these drugs. So the development of cancer treatments now focuses on the 
development of new anti-cancer agents which can work more specifically towards 
cancer cells. Anti-cancer agents leading to apoptosis of the cancer cells are the desired 
agents. Monoclonal antibodies are used for cancer treatment too. Rituximab and 
Trastuzumab is an example of the monoclonal antibodies which targets the oneogenic 
transmembrane tyrosine kinase receptor HER-2/neu (Naruse et al, 2002). They react 
with antigen that specifically expressed on the cancer cells and induce apoptosis. 
However, unwanted effects such as hypotension and hypersensitivity reactions may 
develop. "Cytokine-release" reaction can occur and it can be fatal. 
For the treatment of HCC, doxorubicin and 5-fluorouracil are the most studied agents. 
The response rate of HCC towards these agents is always less than 20% but the 
toxicity substantial. As mentioned before, there is no effective therapy that can be 
offered to HCC patients. There is an urgent need to develop new treatment for the 
advanced HCC (Stuart et al., 1993). 
In recent years, the new design of chemotherapy is targeted on the initiation of 
apoptosis of cancer cells. There are several strategies to achieve the target. 
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1. Mitochondria as target: The initiation of the intrinsic apoptotic pathway is carried 
out by inducing some cellular stresses through the application of arsenic trioxide, 
mitomycin c，paclitaxel and cisplatin. Generation of cellular stress will indirectly 
induce apoptosis. Other potential anti-cancer agents may target the mitochondrial 
membrane. Disruption of the mitochondrial membrane potential can release 
pro-apoptotic molecules which can activate apoptosis (Berridge et al., 2009). 
2. Bcl-2 as target: In many cancer cells, there are overexpressions of the 
anti-apoptotic protein Bcl-2. High Bcl-2 to Bax ratio is thought to be related to the 
drug resistance of cancer cells. Downregulation of the Bcl-2 protein can be a 
potential treatment for those cancers with overexpression of such protein. The 
down regulation of the Bcl-2 protein could be done by using antisense 
oligonucleotide. The antisense oligonucleotide could then hybridize with the Bc-2 
transcript so that the protein expression level would be lowered down (Baliga and 
Kumar, 2002). 
3. lAP as target: The inhibitor of apoptosis (lAP) family of protein is anotherfamily 
which can regulate apoptosis. The first member of the family was described as a 
baculovirus gene product that can inhibit the apoptosis by inhibiting the activity of 
caspases. The human homologue of this protein contains highly conserved 
baculovirus lAP repeats (BIR). This type of proteins is found to be highly 
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expressed in certain types of cancers (Gastman, 2001). Inhibition of the lAP 
action can probably have anti-cancer effects. Small molecules acting like the 
naturally occurring antagonist of lAP have been developed such that the actions of 
lAP at cellular level are inhibited. Caspases will not be inhibited by lAP and 
apoptosis could probably occur. Small molecule lAP antagonists mimicking the 
action of SMAC, a mitochondrial pro-apoptotic molecule binding to lAP, have 
been developed. Studies have shown that apoptosis is induced in cancer cells 
which involves the nuclear factor - K B ( N F - K B ) activation. And the subsequent 
production of tumor necrosis factor triggers cell death (Hoeller and Dikic, 2009) 
4. Extrinsic apoptotic pathway as target: Small molecules such as monoclonal 
antibodies targeting the death receptors (e.g. TRAIL) have been developed. These 
monoclonal antibodies mimic the action of the death ligand to trigger apoptosis 
through the extrinsic apoptotic pathway (Ghobrial et al., 2005). 
5. Caspases as target: The caspases have been engineered by fusing one or more 
chemically inducible dimerization domains. There will be protein aggregation 
upon administration of a small lipid-permeable dimerizing drug. The protein 
aggregation will lead to the activation of caspases (Ferreira et al, 2002). 
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1.6 Aim of Study 
To study the anti-cancer effects of tetrandrine by in vitro study of the compound in 
HuH-7 and JHH-4 cell lines. 
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Chapter 2 Materials and Methods 
2.1 Cell culture and treatment 
2.1.1 Cell line used 
HuH-7 
It is a well-differentiated human hepatocarcinoma cell line. It is originated from a 57 
years old male which was a Japanese (Nakabayashi et al., 1982). The cell line is from 
JCRB Cell Bank. Roswell Park Memorial Institute (RPMI) 1640 medium 
supplemented with 10% fetal bovine serum was used as the culture medium of this 
cell line. 
JHH-4 
It is a human hepatocarcinoma cell line originated from a 51 years old Japanese male 
(Homma et al., 1985). The cell line is from JCRB Cell Bank. It is cultured with 
Eagle's minimal essential medium supplemented with 10% fetal calf serum. 
WRL68 
It is a human liver embryo cell line obtained from ATCC. Dulbecco's minimal 
essential medium with 10% fetal bovine serum was used as culture medium. WRL68 
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has the morphologic structure similar to hepatocytes and hepatic primary cultures 
[Gutierrez-Ruiz et al, 1994]. It is usually used as the study model of normal liver 
functions. 
2.1.2 Tetrandrine (Tet) 
It was purchased from Sigma. It has a molar mass of 622.74988 g.mol. 
2.1.3 Chemicals and Reagents 
Table 2.1.3-1 The suppliers of the chemicals and reagents used in cell culture. 
Chemicals and reagents Suppliers 
Trypsin-EDTA 0.25% (IX) Invitrogen 
Roswell Park Memorial Institute (RPMI) 1640 medium 
Qualified Fetal Bovine Serum (FPS) 
Dulbecco's minimal essential medium (DMEM) 
Sodium chloride (NaCl) USB Biochemicals 
sodium dodecyl sulfate (SDS) 
potassium chloride (KCl) 
potassium phosphate (KH2PO4) Sigma chemicals 
sodium bicarbonate (NaHCOs) " 
sodium phosphate (NaH2P04) 
Steritop-GP 500 ml (0.22^im) filter Milipore 
75cm^ culture flask Corning 
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2.1.4 Solution preparation 
Roswell Park Memorial Institute (RPMI) 1640 medium 
One pack of RPMI medium was dissolved in 1000ml of deionized water (啦 0 ) with 
the addition of 2.0 g NaHCOs. The pH of the solution was adjusted to 7.2 after the 
complete dissolution of the powders. The solution was sterilized using a Steritop 
membrane with pore size 0.22|xm and was filtered through the membrane in a culture 
hood. 100ml of fetal bovine serum was added to the filtered RPMI medium to 
complete it. The completed medium was stored at 4口. 
10 X Phosphate-buffered saline (PBS) , 
80 g ofNaCl, 2.0 g of KCl, 14.4 g of NaHsPCU and 2.4 g of KH2PO4 were added to 
900 ml of dH20. The pH of the solution was adjusted to 7.4. The volume of the 
solution was finally made up to 1000 ml by adding d H : � . 
I X PBS 
100 ml of lOX PBS was diluted with 900 ml of dEbO. The pH of the IX PBS was 
adjusted to 7.4. If the solution was used for cell culture, it was autoclaved. 
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Tetrandrine 
0.03 l lg of Tetrandrine was dissolved 50 |il concentrated hydrochloric acid of 12M. 
The resulting solution was added with 950 |il 0.9% sodium chloride solution to make 
a stock of 5 OmM Tetrandrine. The stock solution was stored at 4 • . 
The stock solution was further diluted to the desired concentrations by adding 10% 
fetal bovine serum supplemented RPMI medium. 
2.1.5 Procedures 
Seeding Cells into culture flask 
The whole process was performed in the culture hood. Cells stored in liquid nitrogen 
were thawed in the 37°C incubation. The cells were transferred to a new 
microcentrifuge tube. Then they were centrifuged at 1,000 rpm for 3 min. The 
supernatant was discarded. The cell pellet was washed with PBS. Another 
centrifugation with 1,000 r.p.m. for 3 min was followed after washing. The 
supernatant was discarded. 1 ml of the completed medium was added to resuspend the 
cells. After that，cells were transferred to a new 75 cm^ culture flask with 13 ml 
medium. The flask was stored in a 37�C 5% CO2 - 95% air incubator. 
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Subculturing 
The procedures were performed inside the culture hood. IX PBS and PRMI medium 
were warmed in 37°C water bath before subculturing. The medium in the flask was 
discarded and the flask was washed with PBS for two times. 1 ml of 0.25% 
trypsin-EDTA was added to the flask and incubated at 37°C. The completed medium 
(4 ml) was added into the flask to inhibit the activity of trypsin after complete 
detachment of the cells from the bottom of the flask. The cells were transferred to a 
new 15 ml falcon tube and centrifuged at 1,000 r.p.m. for 3 min. The supernatant was 
discarded and the cell pellet was resuspended in 1 ml medium. 5 of cells was then 
thoroughly mixed with 5 |il of trypan blue and was placed on hemocytometer for cell 
counting. Cell counting was performed under microscope. About 1 x 10^ living cells 
were added back into a new 75 cm^ culture flask added with 13 ml of fresh completed 
medium. The culture flask was placed in a 37°C-incubator with 5% CO2 - 95% air 
incubator. 
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2.2 Cell viability 
2.2.1 Chemicals and reagents 
Table 2.2.1-1 The suppliers of the chemicals and reagents used in cell viability 
assay. 
Chemicals and reagents Suppliers 
Methylthiazolyldiphenyl-Tetrazolium bromide (MTT) USB Biochemicals 
96-well microplate Iwaki 
millex-GP (0.22|im) filter Milipore 
Tetrandrine Sigma Chemical 
Dimethylsulfoxide (DMSO) Fisher Scientific 
2.2.2 Solution preparation 
MTT solution 
MTT (5 mg) was dissolved in 1 ml of PBS to give a concentration of 5 mg/nrl. It was 
freshly made before use. Aluminium foil was used to wrap to falcon containing the 
MTT solution to protect it from exposing to light. 
2.2.3 Procedures 
HuH-7/ JHH-4 (100 |xl) with density of 1 x 10^ cells/cm^ was seeded to 96-well 
microplate. Eight columns with 6 rows of wells were seed with cells using 
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multi-channel pipette. The cells were allowed to seed onto the 96-well microplate for 
overnight in 5% CO2 - 95% air 37口 incubator. All the medium in each well of the 
microplate was removed the following day. Different concentrations of Tet were 
added to the wells. The cells were then incubated Tet for 24，48 and 72 hours inside 
the 5% CO2 - 95% air 370 incubator. 
After the incubation period, 20 |il of MTT solution was added to each well of the 
microplate containing cells. The plate was shaken for 5 minutes to ensure 
homogeneity of the solution. The microplate was incubated at 37°C-incubation for 4 
hours. After incubation, the wells were dried using multi-channel pipette and the 
medium was discarded. DMSO of 200 |il was added to the wells. The solution was 
shaken for 5 minutes using shaking table to dissolve and resuspend the purple 
formazan formed. 200 ul DMSO was added to the unused wells and it acted as a blank 
for the MTT assay. The optical density of the plate was read at wavelength 540 nm 
using microplate reader. The absorbance of the wells with cells treated with different 
concentrations of Tet was compared with the absorbance of the control well. The 
viability of the cells at each of the concentration towards Tet was then calculated. A 
viability curve was then constructed by plotting the viability of cells versus different 
concentrations of Tet used during treatment. The concentration of Tet used to lower 
the cell viability to 50% of the original, i.e. the IC5。，was recorded. 
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2.3 Detection of Apoptosis 广 
2.3.1 Chemicals and reagents 
Table 2.3.1-1 The suppliers of the chemicals and reagents used in apoptosis 
detection assay. 
Chemicals and reagents Suppliers 
EDTA Sigma Chemicals 
Glycerol 












Trackit™ 100 kb DNA ladder 0.1 ug/ul Invitrogen 
6-well plates Iwaki 
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2.3.2 Preparation of solutions 
Cell DNA Lysis buffer 
Tris basel of 1.2114 g, 10 ml of 0.5M EDTA at pH 8.0 and 5 ml of 10% SDS were 
added with dHzO to yield a final volume of 50 ml. The pH of the solution was 
adjusted to 8.3 after complete dissolution of the compounds. 
10 mg/ml Proteinase K solution , 
Proteinase K of 5 mg was dissolved in 0.5 ml of dHsO. 
IX TE buffer at pH8.0 
Tris base of 121.14 mg, 20\i\ of 0.5M EDTA at pH 8.0 was added with dHaO to make 
a final volume of 10 ml. The pH of the buffer was adjusted to 8.0 after complete 
dissolution of the components. 
6 X DNA loading dye 
93.6 III of glycerol, 0.3 mg of bromophenol blue, 3 |il of 0.5 M EDTA at pH 8.0，0.3 
mg of xylene cyanole and d H � � t o a final volume of 250 |il. 
35 
10 X Tris-Borate-EDTA (TBE) buffer 
Tris base of 108 g, 55 g of Boric acid and 9.3 g of Na4EDTA were dissolved in 1000 
ml of distilled water. 
Ethidium bromide (EB) 
It was prepared by dissolving 50 mg of EB in 100 ml of dH20. 
2.3.3 Procedures 
2.3.3.1 DNA extraction form cells 
1 X 10^  cells of HuH7 were seeded onto a 100 mm culture dish. The cells were treated 
with different concentrations of Tet whereas the highest dose was the same as that of 
the IC50 of the incubation time. After the period of incubation, the medium in each 
sample was collected. The cells were washed with IX PBS. Trypsin was added to the 
dishes and the dishes were incubated at 37°C incubator. After all the cell had detached 
from the dishes, they were collected into the 15 ml falcon with the medium originally 
present in the dishes. The cells were collected with centrifugation at 1,000 r.p.m. for 3 
min. The supernatant was discarded and the cell pellets were resuspended in 400 |j,l of 
cell DNA lysis buffer in a 1.5 ml microtube with vigorous mixing. Twenty |j.1 of 10 
mg/ml proteinase K were added to each microtube. The mixtures were incubated at 
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37°C for 3 hrs for complete cell lysis. The samples were cooled to room temperature. 
Saturated NaCl solution of 50 |il was added to each sample. The solution was mixed 
by vortexing. The tubes were centrifuged at 7,000 x g for 15 min at room temperature. 
DNA was retained in the supernatant and the supernatant was collected to a new tube. 
Ice cold absolute ethanol (stored at -20°C) of 1 ml was added to the tubes. The tubes 
were inverted for several times. The tubes were centrifuged at 14,000 x g at 4°C for 
20 min. The supernatant in each tube was discarded leaving the DNA pellets. The 
pellets were washed with 70% ethanol once. They were spun again at 14,000 x g at 
4°C for 20 min. The supernatant was removed and the DNA pellet was allowed to air 
dry to remove all ethanol left. TE buffer of 50 jxl containing 0.2 mg/ml of RNase A 
was added to the DNA pellets for RNA digestion. They were incubated at 37°C for 90 
min in order for the DNA to dissolve completely in the TE buffer. DNA solution of 2 
)xl from each sample was added to 998 |il TE buffer. The concentrations of the DNA in 
the diluted solutions were measured by UV spectrophotometry (Beckman, DU 650) 
using OD260. ‘ 
2.3.3.2 DNA Agarose Gel Electrophoresis 
Agarose of 0.3 g was added to 20 ml TBE buffer. The mixture was heated up using 
microwave in order to dissolve all the agarose powder. Ethidium bromide of 2 }j,l was 
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added to the cooled down agarose solution before it solidified to make an ethidium 
bromide containing 1.5% agarose gel. 10 |il of the dissolved DNA samples was mixed 
with 2 |il 6X DNA loading dye. The mixtures were loaded on the 1.5% agarose gel. It 
was run at 75V for 1 hour. The DNA bands were visualized under UV illuminator. 
The gel was photographed for documentation. 
• 
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2.4 Gene expression in Tet-induced apoptotic cells 
2.4.1 Chemicals and Reagents 
Table 2.4.1-1 The suppliers of the chemicals and reagents used in gene expression 
analysis. 
Chemicals and reagents Suppliers 
Trackit™ 100 kb DNA ladder 0.1 ug/ul Invitrogen 
TRIZOL reagent 
UltraPureTM agarose 
RNeasy Mini Kit™ Qiagen 
5X Green GoTaq Flexi Buffer Promega 
GoTaq® Hot start Polymerase 5 u/ul 
MgCl2 25 mM " 
Transcriptor First Strand cDNA Roche 
GAPDH forward and reverse primer Sigma Chemicals 
p21 forward and reverse primer 
Survivin forward and reverse primer 
Bid forward and reverse primer 
Bax forward and reverse primer 
Bcl-2 forward and reverse primer 
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2.4.2 Preparation and solutions 
Primer mix 
Forward primer of 10 ul and 10 ul reverse primer were added to 80 ul PGR grade 
water to make up the primer mix. 
10 X Tris-Borate-EDTA (TBE) buffer 
Refer to 2.3.3 
Ethidium bromide (EB) 
Refer to 2.3.3 " 
2.4.3 Procedures 
2.4.3.1 Total RNA extraction and cDNA synthesis 
1x10^ HuH-7/JHH-4 cells 
were seeded on 6-well plate and were incubated with 
different concentrations (0, 7.5, 15 and 20 uM for HuH-7 cells and 1，10, 20 and 40 
uM for JHH-4 cells) ofTet. After 24 hours of incubation, cells were harvested by 
trypsinization and were washed by IX PBS. The cell suspensions were centrifuged 40 
with 1,000 rpm for 3 min to collect the cells. The supernatant was removed and 
responded the cell platelet by brief vortexing. 1ml TRIZOL reagent was added to each 
sample. The mixtures were mixed vigorously by vortexing . The mixtures were then 
incubated at room temperature for 5 mins. After incubation, 266 ul chloroform was 
added to each sample and the solution mixtures were mix vigorously by hand for 15s. 
The mixtures were left at room temperature for 2-3 min. After that, the samples were 
centrifuged at 14,000 rpm for 15 mins. After centrifugation, the upper aqueous layer 
in each tube was collected to a new 1.7 microcentrifuge tube. The upper layer would 
then be mixed with 70% ethanol in 1:1 ratio. RNeasy Mini Kit™ from Qiagen was 
used for the total RNA extraction. The procedure for mRNA extraction followed the 
manufacturer's protocol provided. 
After the extraction of total RNA, the total RNA concentration in each sample was 
measured. The same amount of total RNA was used in each sample for cDNA 
synthesis. Transcriptor First Strand cDNA Synthesis Kit from Roche was used for 
cDNA synthesis. The procedure followed the protocol given. 
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2.4.3.2 Reverse-transcribe PGR (RT-PCR) and detection of gene products 
Each RT-PCR reaction mixture contained the following: 
Table 2.4.3.2-1 The components and the corresponding volume of RT-PCR 
reaction mixture. 
Reagent Volume (ul) per reaction 
PGR Grade water 112 . 
5X Green GoTaq Flexi Buffer 4 
MgCl2 25 mM 1.2 .. 
Primer 1 
dNTP 10 mM 0.4 
GoTaq® Hot start Polymerase 5 u/ul 0.2 
cDNA Template 2 
A two steps PGR reaction was set. 
Initilization: 95°C time: 5mins 
Denaturation: 95°C time: 30s 
Annealing and extension (in one step): Depends on the target gene time: 1 min 
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Table 2.4.3.2-2 The annealing and extension temperature used for different 
target genes 





p21 ^ " 
Survivin 60 
After RT-PCR, the PGR products were detected by running a 2% agarose gel. Agarose 
of 0.4 g was dissolved in 20 ml IX TBE buffer. The procedure of setting up the 
agarose gel was the same as that mentioned in 2,3.3. The 2% agarose gel was run at 
100 V for 30 min to separate the PGR products. 
•r* 
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2.5 Protein expression in Tet-induced apoptotic cells 一 
2.5.1 Chemicals and Reagents 
Table 2.5.1-1 The suppliers of the chemicals and reagents used in protein 
expression analysis 
Chemicals and reagents Suppliers 
Aery lam ide USB Biochemicals 
Isopropanol 
SDS powder . , 
Tris-base 
N,N'-methylene-bis-arcylamide 
R o d e o ™ ECL Western Blotting Reagents 
Beta-mercaptoethanol Sigma Chemicals 
bromophenol blue 
calcium chloride (CaCb) 
Sodium vanadate (NagVCU) 
TEMED 
Methanol Fisher Scientific 
3 MM Chromatography paper Whatman 
0.2 um PVDF transfer membrane Pall 
0.45 um PVDF transfer membrane 
SuperRX Medical X-Ray film 
PageRuler™ Prestained Protein Ladder Fermentas Life 
GAPDH antibody Ambion, Inc. 
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Bax (B-9) antibody Santa Cruz 
Bcl-2 (C-2) antibody d . “ i - t Biotechnology, Inc. 
PCNA(PCIO) antibody 
Caspase-9 antibody (Human Specific) Cell Signaling 
cleaved Caspase-9 (Asp330) antibody (Human Specific) Technology 
PARP Antibody 
cleaved PARP (Asp214) 
anti-rabbit IgG HRP-linked antibody 
Tween® 20 Invitrogen 
Zymax™ Goat anti-mouse IgG, HRP-conjugated antibody 
Calcium Plus Skimmed Milk Powder Carnation 
DC™ Protein Assay Bio-Rad 
2.5.2 Preparation of solutions 
Whole cell protein lysis buffer 
SDS of 1%, ImM Na3V04, 10 mM Tris, 5 mM CaCb were mixed and thejiH was 
made to pH 7.4. 
BSA standard (4 mg/ml) 
BSA standard was dissolved into 1 ml of whole cell lysis buffer. The standard buffer 
was stored at -20 
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2 X SDS sample loading buffer 
Bromophenol blue of 0.00625 g, 2.5 ml of 14.4 M beta-mercaptoethanol, 2.5 ml of 
IM Tris HCl at pH 6.8, 10 ml of 10% SDS, 5 ml of glycerol were mixed and dHaO 
was added to make up the final volume to 25 ml. it is kept at -20°C. 
IMTris-HCl (pH 8.8) 
Tris base of 12.114 g was dissolved in 80 ml of dHaO and the pH was adjusted to 8.8 
with HCl. The solution was made up to 100 ml with dHsO. 
1.5MTris-HCl (6.8) 
Tris base of 18.171 g was dissolved in 60 ml of dHaO and the pH was adjusted to 6.8 
using HCl. The solution was made up to 100 ml with dHzO. 
10% SDS 
It was made by dissolving 10 g of SDS in 100 ml of dHsO. 
30% Acrylamide/Bis 
Acrylamide of 29 g and 1 g of bis-acrylamide were dissolved in 100 ml of dHsO. It is 
stored at 4®C. 
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10% ammonium persulfate 
Ammonium persulfate of 0.1 g was dissolved in 1 ml of dHzO and was kept at -20®C. 
Running gel 12% 
Tris-Cl at pH 8.8 in 1.5 M of 1.04 ml, 1.28 ml of distilled H2O, 1.6 ml of 30% 
acrylamide/Bis mixture, 40 |j,l 10% SDS, 40 |li1 10% ammonium persulfate and 5 jj.1 
TEMED were mixed. 
Stacking gel 4% 
Tris-Cl at pH 6.8 in 0.5 M of 1.25 ml, 1.48 ml of distilled H2O, 0.335 ml 30% 
acrylamide/Bis mixture, 25 |j,l 10% SDS, 12.5 |j1 10% ammonium persulfate and 5 ul 
TEMED were mixed. 
lOX running buffer 
SDS (10%) of 100 ml, 30.2 g of Tris-base and 188 g of glycine were mixed and the 
final volume was made up to 1000ml using dHaO. 一 
IX running buffer 
One hundred milliliter of lOX running buffer was diluted with 900ml dHsO. 
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Transfer buffer 
Glycine of 2.93 g, 5.82 g of Tris，200 ml of Methanol and 3.75 ml of 10% SDS were 
mixed and made up to the final volume of 1000ml using dHsO. 
IX Tris-buffered saline/Tween (TEST) buffer 
It containedlO mmol of Tris-HCl at pH- 7.5, 150 mmol NaCl and 0.1% Tween. 
Blocking solution (5%) 
Non-fat milk powder ofO.l g was dissolved in 2 ml IX TBST. 
2.5.3 Procedures 
2.5.3.1 Cell treatments 
HuH-7 cells were seed into a 100 mm dish with cell number 1 x 10^ Different 
concentrations of Tet were used to treat the cells for 72 hours. 
2.5.3.2 Extraction of whole cell lysate 
HuH-7 cells treated with Tet were trypsinized and collected using centrifugation. The 
number of cells collected in each sample was counted using hemocytometer. Whole 
cells lysis buffer of 200 |j,l was added per 1 x 10^ cells. The cells were mixed 
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vigorously and were kept at 37 for 30 min. After incubation, the samples were 
placed in boiling water for 10 min. The samples were spun at 14000 x g for 15 min. 
The supernatant of the samples were collected in a new microcentrifuge tube for the 
protein concentration determination. 
2.5.3.3 Determination of protein concentration 
The protein concentration was determined by using Bio-Rad DC Protein Assay. 
Reagent S and Reagent A provided by the assay were mixed in a ratio of 1:50. On the 
other hand, 2 |LI1 of the extracted protein sample was mixed with 3 |il of the whole cell 
lysis buffer in 96-well plate. Five different concentrations of the protein of 5 |xl 
standard solution, from 4 mg/ml to 0.25 mg/ml, prepared by serial dilution were also 
added to the 96-well plate. The mixture of Reagent S and A of 25 jxl was added to 
each wll. Reagent B of 200 \i\ was added to the wells and the absorbance of the 
resulting solution was measured using 595 nm. A standard curve (Figure 2.4-1) was 
constructed by plotting different concentrations of protein standard versus the 
corresponding absorbance at 595 nm. The protein concentration in the sample was 
determined using the standard curve. 
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Protein standard curve at 595nm 
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Figure 2.5.3.3-1 The protein standard curve of Bio-Rad DC Protein Assay at 595 
nm 
2.5.3.4 Protein gel electrophoresis by SDS-PAGE •‘ 
Mini-PROTEAN® III cell from BioRad was used as the electrophoresis system to 
perform sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). 
Running gel solution was set and poured into the gel casting form. A small quantity of 
isopropanol was layered on the top of the running gel solution and waited for its 
solidification. The isopropanol was discarded and 啦 0 was used to wash the gel. 4% 
of the stacking gel solution was then added onto the top of the running gel. A 10-tooth 
comb was inserted. The gel was allowed to stand until it polymerized. 2 X sample 
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loading dye was added to the protein samples in 1:1 ratio and the resulting mixtures 
were boiled at 100°C for 10 min. Samples were then loaded into the wells and 1.5 ul 
o f P a g e R u l e r ™ Prestained Protein Ladder was added as protein marker.. The gel was 
allowed to run at constant voltage. 50V was used for running the stacking gel where 
80V, lOOV and 120V were used for running 10%, 12% and 15% running gel 
respectively. The SDS-PAGE was stopped after the dye front containing bromophenol 
blue reached the bottom of the gel. 
2.5.3.5 Western blotting 
Bio-Rad semi-dry Trans-Blot electroblotter was used to transfer the protein onto the 
membrane. The gel was removed and was immersed into transfer buffer for 15 min 
for equilibration. Six pieces of Whatman 3 MM paper and PVDF membrane were cut 
into the same size as the running gel. The PVDF membrane was activated using 100% 
methanol and was washed twice using cfflbO to remove methanol. It was then 
equilibrated in transfer buffer for 15 min. 3 MM Whatman papers were thoroughly 
wet with transfer buffer. Three pieces of Whatman paper were placed at the bottom of 
the semi-dry transfer system. PVDM membrane was layered on top of the papers and 
the running gel was placed above the membrane with another 3 pieces of paper coving 
it. A test tube was used to roll on the filter papers in order to remove the trapped air 
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bubbles in between each layer. Constant current of 0.1 A was used to transfer protein 
for 2 hr. The PVDF membrane was carefully removed using forceps and was rinsed 
with TEST buffer for several times. The membrane was blocked in non-fat milk 
solution at room temperature for 1 hour. Depending on the proteins to be detected, 
different percentages of non-fat milk solution were used for blocking. The desired 
dilution of antibody was prepared by adding antibody into the suitable percentage of 
non-fat milk solution which was the same as that used in blocking. The membrane 
was finally blotted with different antibodies overnight at 4°C. 
The next day, the membrane was washed with IX TBST containing 0.2% Tween 20 
three times, 15 min each. After washing, the membrane was blotted with the 
corresponding secondary antibody. The dilution for anti-mouse and anti-rabbit were 
1:10000 and 1:6667 respectively. The secondary antibodies were diluted in non-fat 
milk solution. The blocking solution should contain the same concentration of non-fat 
milk as that for primary antibody. The membrane was agitated for 1 hour at room 
temperature. After probing with secondary antibody, the membrane was washed with 
IX TBST containing 0.1% Tween 20 solution for three times, each with 10 min. 
Rodeo™ ECL Western Blotting Reagents from USB Biochemicals was used for 
signal development. The two reagents in the kit were mixed in 1:1 ratio. The mixture 
would then be equilibrated at room temperature for 5 min before use. Excess TBST 
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solution on the membrane was removed by blotting it onto a M-fold tissue paper. The 
western blotting reagent mixture was added slowly onto the membrane with the size 
mobilized with proteins faced upward. Protein bands on the membrane were 
visualized after exposing to Fuji Super RX film. The intensities of the bands were 
analyzed using Image J program. 
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2.6 Cell cycle analysis of Tet treated cells 
2.6.1 Chemical and Reagent 
Table 2.6.1-1 The suppliers of the chemicals and reagents used in cell cycle 
analysis 
Chemicals and reagents Suppliers 
Propidium iodide (PI) Sigma Chemicals 
RNase A USB Biochemicals 
2.6.2 Solution preparation 
40 ^g/ml PI solution 
It was prepared by dissolving 400 jxg PI into 10 ml IX PBS. 
100 ng/ml RNase A solution 
RNase A of 100 fxg was dissolved in 1 ml d H2O. 
2.6.3 Procedure 
2.6.3.1 Cell treatments " 
HUH-7 cells were seed into a 100 mm dish with cell number 1 x 10^ Different 
concentrations of Tet were used to treat the cells for 72 hours. 
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2.6.3.2CelI fixing 
The Tet-treated HuH-7 cells were trypsinized and were collected in a 15 ml falcon. 
The cell suspension was centrifuge using 3,000 x g for 3 min. The supernatant was 
discarded and the cells were resuspended in 1 ml IX PBS. The solution was 
centrifuged again using 3,000 x g for 3 min. The supernatant was discarded and the 
cells were resuspended. 2 ml -20 口 70% ethanol was added to the cells with vortexing. 
The solution was then stored at -20 • for flow cytometry analysis. 
2.6.3.3 Flow cytometry analysis 
The fixed cells in ethanol were collected after centrifuging the solution with 3,000 x g 
for 3 min. The supernatant was discarded and the cells were resuspended using RNase 
containing PBS solution. The solution was centrifuged again using 3,000 x g for 3 
min. The supernatant was discarded and the cells were resuspended. One miHiliter PI 
solution was added to the cells and the cells were stained for 15 min before the 
analysis. The DNA content of the treated cells was recorded and analyzed by 
FACScanto flow cytometer. 
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Chapter 3 Result 
Figure 3.1-1 shows the cell viability of HuH-7 cells after treatment with different 
concentrations of Tet for 24 and 48 hours. The viabilities of cells decreased when the 
Tet concentration added was increased at both time points. Both of the viabilities at 24 
and 48 hours dropped significantly after the Tet concentration was increased from 
3.125 to 25.0 uM. The IC50 of 24 and 48 hours were found to be 20.8 uM and 8.0 uM, 
respectively. For the 48 hours incubation period, the cell viability at every Tet 
concentration was found to be lower than that of the 24 hours incubation. 
Figure 3.1-2 shows the cell viability of JHH-4 cells after treatment with different 
concentrations of Tet for 24, 48 and 72 hours. The viabilities of cells also dropped 
with increasing dose of Tet at each time point. The IC50 for 24, 48 and 72 hours of 
incubation were found to be 40.0 uM，28.5 uM and 12.3 uM respectively. The 
viability at each concentration of Tet also decreased with the time. 
Figure 3.1-3 shows the effect the Tet on WRL68 cells after 24, 48 and 72 hours 
incubation. The cell viability of WRL68 cells dropped significantly between 0 to 12.5 
uM of tet. The decrease of cell viabilities became smaller for all of the three time 
points. The IC50 for 24, 48 and 72 hours were found to be 74.5, 43.0 and 35.5 uM 
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respectively. 
Figure 3.1-4 shows the DNA fragmentation ofTet-treated HuH-7 cells. DNA ladders 
were observed in the Tet-treated samples. The control showed no ladder and the DNA 
ladder started to appear when the concentration of Tet was increased to 15 uM. HuH-7 
cells which were treated with 20 uM of Tet showed higher intensity of the light bands. 
The thickness of the ladders also increased compared with that in 15 uM Tet-treated 
sample. 
Figure 3.1-5 shows the effects of Tet on cell cycle distribution ofHuH-7 cells, (a)-(c) 
are the graphical representation of cell populations in Gi，S and G2 phases. The cell 
percentage in each phase of the cell cycle was analyzed by FAC Express. The 
percentages of cells in Gi，S and G2 phases were analyzed. All the three time points 
showed increased cell population in Gi phase after the cells were treated with Tet. For 
24 hours of treatment, the cell population in Gi phase increased from 58.63% to 
71.72%. For 48 hours, it increased from 49.30% to 68.74% while that for 72 hours 
increased from 58.30% to 72.15%. For the cell population within S phase, the 
percentages decreased slightly from 18.07% to 16.95% for 24 hours, 25.88% to 
16.14% for 48 hours and 19.47% to 12.09% for 72 hours incubation. The cell 
population within G2 phase also decreased at all time points. It decreased from 2.30% 
to 11.33%, 24.83% to 15.14% and 22.24% to 15.76% for 24，48 and 72 hours of 
incubation, respectively. 
(d) shows the result from RT-PCR analysis ofp21 gene. The photo shown is 
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representative from three individual experiments. The fold changes were calculated 
relative to the control. The mRNA expression for p21 gene was significantly 
increased to 4.337±0.330 folds for 20 uM Tet treated cells. 
(e) and (f) show the results from the Western blot analysis of p21 and PCNA proteins, 
respectively. Those are the representative blots from three independent experiments. 
p21 protein expression increased to 2.029士0.337 folds compared with the control. 
PCNA protein expression was shown to be decreased to 0.477士0.180 folds for 20 uM 
Tet used. 
Figure 3.1-6 shows the apoptosis-related gene expression levels in HuH-7 cells after 
24 hours treatment with Tet. The mRNA expressions for (a) box’ (b) bid, (c) survivin 
and (d) bcl-2 were studied. (p�GAPDH vms used as the control gene. Both bid and bax 
showed increased mRNA expressions with Tet concentrations. The expressions for bid 
and box increased to 1.594士0.078 and 7.267±0.833 folds for 20 uM Tet used,-
respectively. However, the gene expressions for survivin and bcl-2 were found to be 
decreased with Tet concentrations. The expression of survivin decreased to 
0.583±0.158 folds for 20 uM Tet used. 
Figure 3.1-7 shows the apoptosis-related gene expression levels in JHH-4 cells after 
24 hours treatment with Tet. The mRNA expressions for (a) bax, (b) bid, (c) bcl-2 and 
(d) p21 and (e) survivin were studied, (f)G/4PZ)//was used as the control gene, hid, 
bax and p21 showed increased mRNA expressions with Tet concentrations. The 
expressions of bid increased to 3.362士0.672 folds, bax expression increased to 
2.100±0.236 andp21 expression increased to 6.778±1.249 folds for 40 uM Tet used. 
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However, the gene expressions for survivin and bcl-2 were found to be decreased with 
Tet concentrations. The expression of bcl-2 decreased to 0.357士0.061 folds for 40 uM 
Tet used. 
Figure 3.1-8 shows the apoptosis-related protein expressions in HuH-7 cells after 24 
hours treatment with Tet. The levels of (a) PARP and cleaved PARP, (b) procasepase-9 
and cleaved caspase-9, (c) Bcl-2, (d) procaspase 3 and (e) Bax were analyzed by 
Western blotting. (e)G^PZ)//was used as the control gene. The bar charts in (a) and 
(b) represent the fold changes of PARP and procaspase 9 at different Tet 
concentrations respectively. PARP expression decreased with Tet concentrations. Its 
expression was reduced to 0.498士0.161 folds for 20 uM. The cleavage product of 
PARP, the cleaved PARP, increased in expression. Procaspase 9 showed decreased 
expression to 0.288士0.222 folds of the control where the amount of cleaved caspase 9 
increased after Tet treatment. Bcl-2 and procaspase 3 proteins also showed reduced 
expressions after treatment. The amount of Bcl-2 protein was 0.550士 0.130 folds of the 
control. The amount of Bax was elevated after Tet treatment. " 
Figure 3.1-9 shows the apoptosis-related protein expressions in JHH-4 cells after 24 
hours treatment with Tet. The levels of (a) PARP and cleaved PARP, (b) procaspase-9 
and cleaved caspase-9, (c) procaspase 3, (d) Bax, (e) PCNA and (f) Bcl-2 were 
analyzed by Western blotting. (q)GAPDH was used as the control gene. The bar charts 
in (a) and (b) represent the fold changes of PARP and procaspase 9 respectively. 
PARP expression decreased with Tet concentrations. Its expression was reduced to 
0.3 8 8士0.175 folds at 40 uM. The cleavage product of PARP, the cleaved PARP, 
increased in expression. Procaspase 9 showed decreased expression to 0.352士0.191 
folds of the control where the amount of cleaved caspase 9 increased after Tet 
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treatment. PCNA, Bcl-2 and procaspase 3 also showed reduced expressions after 
treatment. The amount of procaspase 3 was reduced to 0.190±0.082 folds of the 
control. The amount of PCNA was reduced to 0.331 士0.161 folds at 40 uM Tet used. 
Bax showed elevated protein expression after treatment. The amount of it was 
elevated to 1.467±0.070 folds of the control at 40 uM Tet used. 
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Figure 3.1-1 Effect of Tet on the cell viability of HuH-7 cells 
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Figure 3.1-1 HuH-7 cells were seeded in 96-well microplates and were incubated 
with different concentrations of Tet for 24 and 48 hours. The viability of the cells was 
measured by MTT assay using DMSO as blank. The values are the mean of three 
individual experiments. The data represent the mean 士 SD (n=3). 
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Figure 3.1-2 Effect of Tet on the cell viability of JHH-4 cells 
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Figure 3.1-2 JHH-4 cells were seeded in 96-well microplates and were incubated 
with different concentrations of Tet for 24，48 and 72 hours. The viability of the cells 
was measured by MTT assay using DMSO as blank. The values are the mean of three 
individual experiments. The data represent the mean 士 SD (n=3). 
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Figure 3.1-3 Effect of Tet on the cell viability of WRL68 cells 
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Figure 3.1-3 WRL68 cells were seeded in 96-well microplates and were incubated 
with different concentrations of Tet for 24，48 and 72 hours. The viability of the cells 
was measured by MTT assay using DMSO as blank. 
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Figure 3.1-4 Effect of Tet on DNA integrity ofHuH-7 cells. 
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Figure 3.1-4 HuH-7 cells were incubated with 0, 7.5，15 and 20 uM Tet for 24 hours. 
DNA contents extracted were analyzed by agarose gel electrophoresis with 2% 
agarose gel. The DNA ladders were visualized using UV illuminator after staining 
with ethidium bromide. 
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Figure 3.1-5 Effects of Tetrandrine on the cell cycle distribution ofHuH-7 cells. 
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Figure 3.1-5 (a)-(c) The bar charts show the percentages of cells in different phases of 
the cell cycle after (a) 24, (b) 48 and (c) 72 hours treatment with 0，5 and 10 uM of 
Tet. (d) Levels ofp21 gene were estimated using RT-PCR analysis after 24 hours 
treatment with Tet. (e) and (f) Levels of p21 and PCNA proteins were estimated after 
24 hours treatment with Tet. The results show the representative photos from three 
individual experiments. Average of three independent analyses from 0，7.5，15 and 20 
uM Tet treatment is shown in the bar chart. Statistical significance was evaluated 
using Student's t-test. P values were calculated by comparing the treated groups to the 
control (0 uM Tet). Error bars represent 士 SD. Fold changes are calculated relative to 
the control. 
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Figure 3.1-6 HuH-7 cells were treated with 0, 7.5, 15 and 20 uM Tet for 24 hours. 
The mRNA in the samples was extracted and was converted to cDNA. The gene 
expression levels of (a) bax, (b) bid, (c) survivin and (d) bcl-2 were evaluated by 
reverse-transcribe PGR. GAPDHV^AS used as the control. The results show the 
representative photos from three individual experiments. Average of three 
independent analyses from 0, 7.5, 15 and 20 uM Tet treatment is shown in the bar 
chart. Statistical significance was evaluated using Student's t-test. P values were 
calculated by comparing the treated groups to the control (0 uM Tet). Error bars 
represent 士 SD. Fold changes are calculated relative to the control. 
*The result of bcl-2 is the representative photo from two individual experiments. 
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Figure 3.1-7 JHH-4 cells were treated with 0，10, 20 and 40 uM Tet for 24 hours. The 
mRNA in the samples was extracted and was converted to cDNA. The gene 
expression levels of (a) box, (b) bid, (c) bcl-2 and (d) p21 and (e) survivin were 
evaluated by reverse-transcribe PGR. (f) GAPDH used as the control. The results 
show the representative photos from three individual experiments. Average of three 
independent analyses from 0, 7.5，15 and 20 uM Tet treatment is shown in the bar 
chart. Statistical significance was evaluated using Student's t-test. P values were 
calculated by comparing the treated groups to the control (0 uM Tet). Error bars 
represent 士 SD. Fold changes are calculated relative to the control. 
*The result of survivin is the representative photo from two individual experiments. 
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Figure 3.1-8 HuH-7 cells were treated for 24 hours with 0，7.5，15 and 20 uM 
Tetrandrine and equal amounts of cell lysates (60 ug) were subjected to 
electrophoresis. The levels of (a) PARP and cleaved PARP, (b) procasepase-9 and 
cleaved caspase-9, (c) Bcl-2, (d) procaspase 3 and (e) Bax were analyzed by Western 
blotting, (f) To ensure equal loading, the same blot was stripped and reprobed with 
anti-GAPDH which was used as the loading control. The results show the 
representative Western blots from three individual experiments. Average of three 
independent analyses from 0, 7.5，15 and 20 uM Tet treatment is shown in the bar 
chart. Statistical significance was evaluated using Student's t-test. P values were 
calculated by comparing the treated groups to the control (0 uM Tet). Error bars 
represent 士 SD. Fold changes are calculated relative to the control. 
*The results of procaspase 3 and Bax are the representative photos from two -
individual experiments. 
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Figure 3.1-9 JHH-4 cells were treated for 24 hours with 0，10, 20 and 40 uM 
Tetrandrine and equal amounts of cell lysates (60 ug) were subjected to 
electrophoresis. The levels of (a) PARP and cleaved PARP, (b) procaspase-9 and 
cleaved caspase-9, (c) procaspase 3，（d) Bax, (e) PCNA and (f) Bcl-2 were analyzed 
by Western blotting, (g) To ensure equal loading, the same blot was stripped and 
reprobed with anti-GAPDH which was used as the loading control. The results show 
the representative Western blots from three individual experiments. Average of three 
independent analyses from 0，7.5，15 and 20 uM Tet treatment is shown in the bar 
chart. Statistical significance was evaluated using Student's t-test. P values were 
calculated by comparing the treated groups to the control (0 uM Tet). Error bars 
represent 士 SD. Fold changes are calculated relative to the control. 
*The results of cleaved PARP and Bcl-2 are the representative Western blots from two 
individual experiments. 
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Chapter 4 Discussion 
Tetrandrine (Tet) is a naturally occurring compound that can be isolated from the root 
ofStephania Tetrandra S. Moore. Studies have shown that Tet has pharmacological 
properties and has high potential to be developed into anti-cancer agent. However, its 
anti-cancer action has not been fully understood. In order to evaluate the potential of 
the compound, the effects of Tet on cancer cells were studied. The mechanism in 
which it can inhibit HuH-7 and JHH-4 cell growth was studied in the present 
investigation. 
2.4.1 Dose- and time-dependent inhibitory effect of Tet were found on HuH-7 cell 
line and JHH-4 cell lines. 
The effect of Tet on the proliferation of the two liver cancer cell lines, HuH-7 cells 
and JHH-4, was studied. Figure 3.1-1 and 3.1-2 show that the cell viabilities for both 
cell lines decreased after treatment with Tet. It indicates that the inhibitory effect of 
Tet on these two cell lines-is dose-dependent. Besides, the cell viability ofHuH-7 
cells at each of the Tet concentration tested decreased with incubation time, i.e. the 
viability decreased from 24 hours to 48 hours of incubation at every tested 
concentration. The IC50 decreased from 20.8 uM to 8.0 uM for HuH-7 cells. The same 
phenomenon could be observed in JHH-4 cells. The IC50 decreased from 40.0 uM to 
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28.5 uM, and finally reached 12.3 uM when the cells were incubated for 24 to 72 
hours. It demonstrates that Tet inhibits the growth of these two cell lines in 
time-dependent manner. 
Doxorubicin is an anticancer drug commonly used to treat liver cancer nowadays. 
Studies found that its IC50 for HepG2 cells after 36h incubation was 16.2ug/ml (Lee et 
al., 2002). This corresponds to 29.8 uM for 36h incubation which is much higher than 
9.0uM for Tet (Yoo et al., 2002). The IC50 of another well-known anti-cancer drug, 
mitomycin C, was found to be 27uM in HepG2 after 24h incubation (Yang et al., 
1997). The inhibitory effect of tet on HepG2 cells is also stronger than mitomycin C. 
Tet also shows smaller IC50 than some other natural compounds towards HepG2 cells. 
Pheophorbide a is an active component in Scutellaria barbata. It showed an IC50 of 
10.0 uM for HepG2 cells after 48h incubation (Tang et al., 2007). The IC50 for an 
essential oil in Curcuma wenyujin (CWO) was found to be 70 uM for 48h (Xiao et al., 
2008). The IC50 found was comparable with the anti-cancer agents used nowadays. It 
implies that Tet has high potential in developing into an effective anti-cancer drug. 
2.4.2 Tet is more selective towards liver cancer cells. 
WRL68 was used as the model to investigate the effect of Tet on normal liver cells. 
MTT assay was performed with the Tet concentrations ranging from 0 uM to 1*00 uM 
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for three time points - 24，48 and 72 hours. Tough tet also showed inhibitory effect on 
the proliferation ofWRL68, the IC50 of each time point was found to be much higher 
than the other two hepatocarcinoma cell lines. For 24 hours incubation, 50% of 
WRL68 was inhibited by 74.5 uM tet where HuH-7 and JHH-4 cells were inhibited 
by 20.8 uM and 40.0 uM tet respectively. For 48 hours incubation, 43.0 uM tet had to 
be used to inhibited WRL68 proliferation by half. Only 8.0 uM and 28.5 uM tet were 
good enough to inhibited HuH-7 and JHH-4 cells. It implies that Tet does not impose 
much inhibitory effect on normal liver cells compared with hepatocarcinoma cells. 
There are significant differences between the IC50 ofWRL68 and the cancer cells 
used at every time point. Hence, the growth inhibitory effect of tet is more selective 
towards the liver cancer cells tested than the normal liver cells. So there are 
considerable therapeutic windows for Tet to work on killing the cancer cells, leaving 
the other normal liver cells relatively unaffected. 
2.4.3 The cell death in HuH-7 cells induced by Tet is mediated through apoptosis 
The cell death induced by Tet is believed to be apoptotic. The result from the DNA 
fragmentation assay shows clearly that DNA ladders were detected in the Tet treated 
HuH-7 cells. As DNA fragmentation is the hallmark of apoptosis, it is supporting 
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evidence that Tet causes the death of cancer cells through the initiation of apoptosis. 
When the Tet concentration increased, the amount of small molecular weight ladders 
also increased with decreased light intensity for the bands at the top of the agarose gel. 
It implies more genomic DNA molecules were cleaved to form smaller DNA 
fragments at higher Tet concentrations. 
HuH-7 cell line is a p53 gene mutated cell line. In the absence of the functional p53 
protein, apoptosis can still occur in HuH-7 cells suggesting that the Tet-induced cell 
J* 
death does not require the activation of p53 gene. It implies that it will be a useful 
anti-cancer agent if it is used to treat HCC targeting p53 mutant. 
2.4.4 Tet induces Gj phase cell cycle arrest as part of its mechanism in inducing 
apoptosis in HuH-7 cells. 
Studies show that there is a linkage between proliferation and apoptosis. The cells 
have to passthrough the cell cycle checkpoint before it can proliferate. Otherwise, the 
cells will be arrested for repair or apoptosis will finally take place. So cell cycle arrest 
of cancer cells is a good sign of their cell death. The results of the cell cycle analysis 
by flow cytometry show that the percentage of cells in S phase and G2 phase 
decreased whereas Gi phase increased with increasing dose of Tet at all the time 
points tested. It means the cells accumulated at Gi phase after treatment. It suggests 
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that Tet inhibits cell proliferation at a very early stage within the cell cycle. The 
process of which the cells proceed to S phase during cell cycle is inhibited by the 
action of Tet. 
The ability of Tet to induce Gi phase cell cycle arrest in HuH-7 cells was first 
confirmed by RT-PCR and then also confirmed by Western blot analysis. p21 gene 
expression was analyzed by RT-PCR using GAPDH as the control. The increased 
band intensity indicates that the gene expression level for p21 increased with the Tet. 
In the Western blots for p21 and PCNA shown in Figure 3.1-11 which used GAPDH 
as the control, the protein expression for p21 increased where that of PCNA decreased. 
It is known that p21 binds to cyclin-CDK 2 or -CDK 4 complexes and inhibits their 
activities. p21 plays an important role in cell cycle regulation by controlling the cell 
cycle progression from Gi phase to S phase. It also binds to the proliferation cell 
nuclear antigen (PCNA). It is synthesized in the early Gi phase and S phase during the 
cell cycle. PCNA is an auxiliary factor which increases the processivity of DNA 
polymerase 5 and in turn increases the rate of DNA synthesis during S phase of the 
cell cycle. It is an important protein responsible for the regulation of DNA synthesis. 
So it serves as a marker for proliferating cells. The binding of p21 to PCNA inhibits 
the role of PCNA during DNA replication. So the decreased protein expression for 
PCNA indicates that there were less cells entering S phase after treatment with Tet. 
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The higher dose of Tet used, the stronger the inhibitory effect exerted on HuH-7 cells 
on proceeding from G! phase to S phase. Hence, there was less proliferating cells and 
larger population of cells was retained in Gi phase after treatment. The data from 
RT-PCR and Western blot also support that Tet induces Gi phase cell cycle arrest. 
C. ‘ 
2.4.5 Tet could probably induce Gj cell cycle arrest in JHH-4 cells 
From Figure 3.1-7, the gene expression analysis of JHH-4 cells after Tet treatment for 
24 hours showed increased expression of p21. And Western blot analysis (Figure 
3.1-9) showed decreased PCNA protein expression. Though the upregulation ofp21 
was confirmed at the gene level, the PCNA was downregulated at the protein level. 
That means there were less JHH-4 cells entering S phase after Tet treatment for 24 
hours. It is believed that p21 protein expression was also elevated so that it bound to 
cyclin-CDK complexes and inhibited the cell progression from Gi phase to S phase. 
Hence the amount of PCNA detected after treatment decreased. Gi phase cell cycle 
arrest could probably be induced by Tet in JHH-4 cells. , 
2.4.6 Tet-induced apoptosis involves the intrinsic, caspase-dependent pathway in 
both the HuH-7 and JHH-4 cell lines. 
Caspases play active roles in controlling the event of apoptosis molecularly. They are 
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involved in both the initiation and execution of the programmed cell death. Western 
blot analysis carried out in the present study proves that Tet-induced cell death 
involves apoptosis. 
The result shows that the protein expression for procaspase-9 in both the HuH-7 and 
JHH-4 cell lines decreased in dose-dependent manner. Besides, the expression for the 
cleaved, active caspase 9 was found to be increased in dose-dependent manner 
(Figure 3.1-8 (b) and 3.1-9 (b)). As caspase 9 is the initiator for the intrinsic apoptotic 
pathway, the cleavage of pro-caspase 9 to form the active caspase 9 is essential for 
inducing cell death in Tet-treated HuH-7 and JHH-4 cells and intrinsic apoptotic 
pathway is involved in the anti-cancer mechanism of Tet. 
In the intrinsic apoptotic pathway, the molecular substrate for active caspase 9 is 
procaspase 3. So the next protein target to be investigated is pro-caspase 3. In the 
western blots of pro-caspase 3 in both cell lines (Figure 3.1-8 (d) and Figure 3.1-9 (c))， 
it was found that the protein expressions decreased dose-dependently. It can further 
confirm that Tet can activate the caspase cascade of the intrinsic apoptotic pathway. 
Besides, the protein expression for full-length PARP decreased significantly in both 
cell lines. The amount of cleaved PARP also increased in dose-dependent manner. 
PARP, an important protein for DNA repair, is the molecular substrate of active 
caspase 3. The occurrence of PARP cleavage is associated with DNA fragmentation in 
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cells and finally leads to cell death. The result is concordant with the DNA integrity 
analysis for HuH-7 cells shown in Figure 3.1-4 
In the gene expression analysis for HuH-7 cells (Figure 3.1-6)，the survivin expression 
was found to be decreased in a dose-dependent manner. It is reported that survivin is 
an anti-apoptotic protein which exerts its function by binding to caspase 3 and hence 
the caspase 3 activity is suppressed (Kania et al., 2003). The decreased gene 
expression suggests that Tet could promote apoptosis by suppressing the expression of 
survivin. 
2.4.7 Proteins in Bcl-2 family are involved in the inhibitory mechanism of Tet 
The proteins in Bcl-2 family can be classified into two categories, the pro-apoptotic 
and anti-apoptotic proteins. These proteins participate in the apoptotic pathway 
involving mitochondrial control. In the gene expression analysis, the gene expressions 
ofZ>ax(Figure 3.1-6(a) and Figure 3.1-7(a)) and Mcf(Figure 3.1-6(b) and Figure 
3.1-7(b)) increased while Z)c/-2(Figure 3.1-6(c) and Figure 3.1-7(d)) was found to be 
decreased in in both cell lines after Tet treatment. Both the bax and bid are 
pro-apoptotic proteins where bcl-2 is anti-apoptotic protein. The pro- and 
anti-apoptotic proteins exert their function in opposite ways. It is reported that Bcl-2 
was overexpressed in HCC(Hussein, 2004) where the expression of Bax was 
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downregulated in HCC tissues(Guo et al., 2002). It is also reported that 
downregulation of Bid was also observed in HCC(Chen et al., 2001). The elevated 
gene expressions of bax and bid, and the suppressed gene expression of bcl-2 suggest 
that these proteins could involve in the apoptotic event which was induced by Jet. 
Besides acting on gene level, the protein level of Bax was also found to be elevated 
after Tet treatment(Figure 3.1-8(e) and Figure 3.1-9(d)). On the other hand, bcl-2 
protein expression was downregulated in both cell lines(Figure 3.1-8(c) and Figure 
3.1-9(f)). It provides supporting evidence that Bax and Bcl-2 do take parts in carrying 
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